We are live on ! Find out more
SXTPW icon

60 Degrees Pharmaceuticals Warrant

8 hedge funds and large institutions have $24.4K invested in 60 Degrees Pharmaceuticals Warrant in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 88 (0)

21% less capital invested

Capital invested by funds: $30.9K → $24.4K (-$6.5K)

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
8
Holders Change
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
2
Reduced
5
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Walleye Capital
1
Walleye Capital
New York
$10K -$51 -799 -0.4%
CS
2
Clear Street
New York
$7.31K +$12 +182 +0.1%
TC
3
Torno Capital
Massachusetts
$2.36K
Mariner
4
Mariner
Kansas
$2K -3 -0%
TSS
5
Two Sigma Securities
New York
$1.14K -$134 -2,080 -8%
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$910 +$71 +1,109 +7%
Citadel Advisors
7
Citadel Advisors
Florida
$621 -$204 -3,174 -20%
UBS Group
8
UBS Group
Switzerland
$35 -$6 -86 -11%

SXTPW Hedge Fund Activity: Q1 2026 in Review

8 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals Warrant (SXTPW) for Q1 2026, worth a combined $24.4K — down 21% from $30.9K a quarter earlier.

Fund positioning in SXTPW was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 5 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $71. The largest seller was Citadel Advisors, cutting an estimated $204.

  • 8 institutional investors held 60 Degrees Pharmaceuticals Warrant (SXTPW) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $24.4K of 60 Degrees Pharmaceuticals Warrant stock for Q1 2026, down 21% quarter-over-quarter.
  • 0 funds opened new 60 Degrees Pharmaceuticals Warrant positions in Q1 2026 and 0 closed out.
  • The largest 60 Degrees Pharmaceuticals Warrant buyer in Q1 2026 was Susquehanna International Group, an estimated $71 added.
  • The largest 60 Degrees Pharmaceuticals Warrant seller in Q1 2026 was Citadel Advisors, an estimated $204 sold.

Based on aggregated 13F filings for Q1 2026.